Article
Genetically engineered mouse models may be an accurate predictor of how cancer-fighting drugs are delivered to melanoma patients, a new study demonstrates.
Daily Derm Times: March 21, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Ritlecitinib Demonstrates Effectiveness in Subgroup Analysis of Asian Patients
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2
730-nm Picosecond Laser Is More Effective Than 1064-nm for Acquired Dermal Melanocytosis